Contract Manufacturing
Today, for approximately every 5,000 to 10,000 compounds that enter preclinical testing, the first step in pharmaceutical development, only one finally reaches the market. From conception to market, all candidates face an uphill battle to become an approved drug, throughout which most will fail due to high toxicity, insufficient efficacy, or because it’s physicochemical properties are incompatible with its intended use.
The decision to go forward with the development of a compound is at the core of any innovative pharmaceutical company today. The earlier a compound can be proved unviable, the more resources and time will be saved. This selection of candidate compounds is becoming increasingly burdensome with the avalanche of New Chemical Entities (NCEs) resulting from the wake of a mapped genome and high-throughput automated testing technologies.
Our Manufacturing Capabilities include:-
Tablet & Capsule Plant
API Plant
Chemcial Plant
Chemcial Plant
Soft Gelatin Plant
Agro Plant
Taj Dearob Pharma have gathered vast experience to become experts at small molecule formulation development, offering preformulation and formulation development services. This helps clients to decide whether to “kill” a compound or let it survive and, in turn, this provides key financial and time saving incentives to our clients. Pharmaceutical and biotech companies can benefit from outsourcing these different services to a single contract organization. By hiring a contractor to perform an array of services from preformulation to end product development, clients can get a full comprehensive service to support their drug development while engendering a strong relationship with a trusted partner.
Contract Manufacturing Capacity
Nowadays, pharmaceutical companies focus their internal capacity on R&D and commercialization functions, whereas drug development is increasingly outsourced to contract providers. This has been happening for years with Big Pharma and more recently with emerging biotech companies that lack drug development capabilities. Worldwide, the demand for the pharma and biopharma outsourcing service is rising significantly.
Manufacturing Pharmaceuticals
Comments are closed.